U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT06980350) titled 'Proposal of a Novel Model for Identifying Complete Response in dMMR Colon Cancer Following Neoadjuvant Immunotherapy' on May 12.
Brief Summary: In this study, we developed a novel evaluation model for identifying complete response following neoadjuvant immune checkpoint inhibitor therapy therapy in patients with dMMR colon cancer, validated its efficacy in two independent cohorts, and assessed its feasibility for W&W strategy.
Study Start Date: July 01, 2018
Study Type: OBSERVATIONAL
Condition:
Colorectal Cancer
Intervention:
DRUG: PD-1 Inhibitors
Patients received at least two doses of anti-PD-1 immunotherapy in a neoadjuvant...